Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 16.3B | 20.9B | 17.4B | 18.3B |
Cost of revenue | 13.3B | 17.1B | 14.3B | 15.1B |
Gross profit | 2.9B | 3.8B | 3.2B | 3.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.8B | 2.1B | 1.6B | 1.6B |
Operating income | 631.1M | 972M | 1.0B | 1.1B |
Non operating interest income | ||||
Income | 25.4M | 38.4M | 34.7M | 40.3M |
Expense | 118M | 209.2M | 159.2M | 156.2M |
Other income expense | 2.4M | 17.3M | 21.5M | 49.3M |
Pretax income | 544.4M | 816.6M | 929.8M | 1.0B |
Tax provision | 102.1M | 171.6M | 217.8M | 238.2M |
Net income | 442.3M | 645M | 712M | 793.1M |
Basic EPS | — | 0.7 | 0.8 | 0.8 |
Diluted EPS | — | 0.7 | 0.8 | 0.8 |
Basic average shares | — | 948M | 948.2M | 956.7M |
Diluted average shares | — | 948.7M | 948.9M | 957.3M |
EBITDA | 1.2B | 1.7B | 1.5B | 1.6B |
Net income from continuing op. | 442.3M | 645M | 712M | 793.1M |
Minority interests | -2.9M | -3.6M | -3.2M | -2.3M |
Preferred stock dividends | — | — | — | — |